This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available:
Mammalian cells are dynamical systems. They detect, adapt and respond to time-varying inputs such as environmental cues, secreted molecules, and mechanical stimuli. These processes are controlled by genes, proteins, small molecules, and their mutual interactions giving rise to gene networks and signalling pathways, often including positive and negative feedback loops. Such gene networks can exhibit nonlinear behaviours, such as multistability and oscillatory dynamics, with important consequences for cellular phenotypes. Despite their individual components being well characterised, operational understanding of how these regulatory networks work is still lacking 1 .
Indeed, understanding how they process and respond to time-varying stimuli and ultimately modify cell behaviour will enable rational modification of cellular processes, an essential capability for biomedicine and biotechnology. Currently, however, it is very difficult, if not impossible in some cases, to apply stimuli with desired amplitudes and temporal dynamics, rather coarse stimuli are often used (i.e. gene over-expression, knock-down, adding or removing a ligand), thus preventing full exploration of network behaviour 2, 3 . The nascent field of Cybergenetics explores how Control Engineering principles can be applied to dynamically steer biological processes at will 4, 5 .
Successful attempts to design control systems to dynamically regulate gene expression have been recently reported in the literature 6 , but mainly in prokaryotes and single-cell eukaryotes [7] [8] [9] [10] [11] [12] [13] . Control systems usually employ a negative feedback approach, where a control algorithm decides the amplitude and duration of the stimulus (e.g. small molecule, ligand, light) to apply to the cell to minimize the difference between the measured and the target fluorescence levels. Experimental control platforms have been implemented using both microfluidics and optogenetics approaches, with the latter reducing actuation time, but requiring significant genetic modification to cells in order to make them responsive to the light input. The application of control engineering to mammalian systems is still very limited. 14 The reason for the slower progress can be attributed to different factors: increased experimental time and costs required to genetically engineer a mammalian cell, slower overall dynamics, and increased sensitivity to environmental conditions (e.g. phototoxicity, shear stress, etc.). All together these factors make the application of control engineering to mammlian cells much more challenging. We recently described a microfluidics platform enabling automatic regulation of gene expression from drug-inducible promoters in mammalian cells 15 . The experimental set-up ( Figure 1a ) consists of a microfluidic device hosted in an inverted fluorescence microscope and two syringes whose position is automatically controlled by stepper motors and connected to the device cell chambers in order to dynamically change the concentration of an inducer molecule 10,11,15 16 . Here, by means of a microfluidics-based platform, we make it possible to precisely and robustly control both gene expression and signalling pathway activity in mammalian cells of biotechnological and biomedical interest, including stem cells ( Figure 1b ). We also implement a bio-hybrid circuit combining biological parts with "virtual" in-silico parts in stem cells to speed up prototyping of biomolecular circuits for Synthetic Biology applications, with relevance to regenerative medicine 17 .
Results
Overview of the control platform. A schematic representation of the experimental platform is shown in Figure 2a . A computer controls the whole platform by: (i) acquiring images at predefined time intervals; (ii) performing image analysis to quantify the phenotype of interest in cells, by means of fluorescent reporters, and the level of the inducer molecule in the device cell chambers, by means of a fluorescent dye; (iii) executing the biological system controller to compute the necessary amount and duration of inducer molecule treatment (control input) for the fluorescence to reach its target value (reference); (iv) executing the inducer molecule controller to move two motorcontrolled syringes to provide inducer molecule to the cells according to the control input (Supporting Information).
Both the inducer molecule controller and the biological system controller follow the Model Predictive Control strategy (MPC), which has previously been applied to control biological systems but never in mammalian cells 8, 9, 11, 12 (Supporting Information). The MPC strategy is preferred to simpler input-output controllers (e.g. PID) as it naturally allows to include experimental constrains such as sampling time and bounded control input in the controller design.
Two motor-controlled syringes, shown in Figure 2b , provide a (time-varying) concentration of an inducer molecule by mixing two fluids (medium with inducer plus fluorescent dye or standard medium). Figure 2c shows an example of an inducer molecule tracking control experiments (Supporting Information, Figure S6 ) where the concentration of tetracycline in the microfluidics cell chamber was automatically regulated by the inducer molecule controller to track a target timevarying concentration (staircase and ramp).
Control of gene expression in Chinese Hamster Ovary cells.
We assessed the feasibility of precisely regulating the expression of a gene of interest from an inducible promoter by means of automated microfluidics feedback control. We stably integrated in Chinese Hamster Ovary (CHO) cells ( Figure 1b ) a tetracycline responsive promoter 18 driving the expression of a fluorescent reporter protein (Ub V76 GFP) destabilised both at the mRNA and protein level 19 . These cells constitutively express the artificial tetracycline-responsive transcriptional activator tTA. When tetracycline is administered to the cells, tTA is not able to bind the promoter preventing expression of the fluorescent report (TET-OFF system). We used a destabilised mRNA, in addition to a destabilised protein, to maximally speed up system dynamics, as these are dictated by both mRNA and protein degradation rates. 19 Indeed, in the absence of the mRNA degradation tag, the dynamics of the system are dominated by the Ub V76 GFP mRNA, whose half-life is about 130 min 19 , even though the Ub V76 GFP protein half-life is just 20 min 19 . On the contrary, when the 3'UTR degradation tag was added, the mRNA half-life became 18 min 19 , thus considerably speeding up the system. In our previous proof-of-principle study 15 , we used a slower degrading protein with an half life of 2 hours (d2YFP) with no mRNA destabilisation. The resulting system dynamics were much slower ( Figure 3b in Fracassi et al 15 ) causing the system to exhibit oscillation when using a PI controller. Moreover, in Supplementary Figure 3 in Fracassi et al 15 , we simulated the action of an MPC controller on that system and found that whereas oscillations disappered, the time taken to reach the set-point was predicted to be approximately 13 hours, thus prompting us to speed up the system dynamics in this current study. We carried out a series of set-point control experiments ( Figure 3 ) to bring the expression of the fluorescent reporter in the cell population at 50% of its maximal value (i.e. stationary expression when no tetracycline is provided to the cells). Achieving and maintaining such level using a classical approach would be very difficult, as tetracycline concentration would have to be precisely titrated due to the strong nonlinearity of the inducible promoter. One syringe is filled with standard growth medium and the other with standard growth medium supplemented with tetracycline at a concentration of 100ng/ml plus sulforhodamine to track tetracycline concentration. We applied two different MPC strategies (Supporting Information) to a set-point control task, one considering a bang-bang control input (i.e. providing either no tetracycline or the maximum concentration of tetracycline), the other considering a continuous control input (i.e. the controller chooses any tetracycline concentration between 0 and 100ng/ml, Supporting Information). The dynamical models used for the implementation of the two MPC strategies are reported in Figures S1 and S2. The results of control experiments are shown in Figure   3 , Figure S3 and Movies S1-S4. Cells reached and maintained the desired fluorescence value across the cell population without exhibiting oscillations, vastly improving our previous results obtained with Relay and Proportional-Integral controllers 15 . Interestingly, and as expected from optimal control theory, even in the case of continuous control inputs, the MPC algorithm chose as the best strategy to achieve the target expression level a bang-bang control input before converging to a fixed concentration of about 50ng/ml (Figure 3c,d) . It is likely that the actual tetracycline concentration in the cell chamber in the case of a bang-bang control input (Figure 3a,b) is indeed a filtered version of the control input because of the delay in the action of the actuator (syrenges and diffusion of the medium), effectively making the two strategies (bang-bang and continuos) similar at the level of actual tetracycline concentration in the cell chamber, which may explain why the performances are so comparable.
Control of gene expression in mouse Embryonic Stem Cells.
To test the generality of our approach, we applied automated microfluidics feedback control to regulate gene expression in a more complex cell type by means of an alternative inducible system. We engineered mouse Embryonic Stem Cells (mESCs) to express the TET-ON transcriptional transactivator tTA and a Degradation Domain (DD) fused mCherry protein from a doxycycline-inducible promoter ( Figure   1b and Supporting Information). In these cells, reporter expression from the inducible promoter is only possible in the presence of the tetracycline analog doxycycline (Dox); furthermore, the smallmolecule ligand trimethoprim (TMP) destabilises the protein in a reversible and dose-dependent manner, allowing for post-translational control 20, 21 . In the set-point control experiments (Figure 4 and Movies S5,S6), we successfully applied the MPC strategy with a bang-bang control input to regulate the expression of the reporter protein at 50% of its maximal value (Supporting Information). The dynamical model used for the implementation of the MPC strategy is reported in Figure S4 .
Single-cell control of mTOR signalling pathway activity. We then applied automated microfluidics feedback control to steer the activity of the mTOR pathway in a single cell. It has been recently demonstrated that the mTOR pathway controls the activity of the transcription factor EB (TFEB), a key player in transcriptional regulation of lysosomal biogenesis and autophagy 22, 23 .
This control is mediated by mTORC1 phosphorylation of TFEB, the latter being sequestered in the cytoplasm. During amino-acid starvation, mTOR signaling is negatively regulated, hence TFEB is no longer phosphorylated and it accumulates in the nucleus inducing transcription of its target genes 24 . The nuclear accumulation of TFEB can thus be used as a quantitative biomarker of mTOR signalling activity 22, 25 . We generated HeLa cells stably expressing a TFEB-GFP fusion protein from a constitutive promoter, in addition to a nuclear mCherry protein to facilitate image analysis ( Figure   1b and Supporting Information). The variable to be controlled is the nuclear TFEB-GFP fluorescence, acting as a quantitative proxy of mTOR activity, whereas the control input is the mTOR inhibitor Torin-1 26 (Figure S5 and Supporting Information). We applied an MPC strategy (Supporting Information) considering a bang-bang control input (i.e. providing either no Torin-1 or the maximum concentration of Torin-1). All of the experiments start with a calibration phase of 180 min in the presence of Torin-1 to estimate the maximal TFEB-GFP nuclear fluorescence when mTOR signalling is inhibited. We performed single-cell set-point control experiments, to bring TFEB-GFP nuclear fluorescence to 50% of its maximum value (Figure 5a These Bio-Hybrid circuits can be used to quickly test hypotheses on the regulatory logic of gene networks and to prototype synthetic circuits. Here, we built a hybrid genetic oscillator in mESC expressing a DDmCherry protein from the doxycycline inducible promoter (Figure 1b ). The hybrid oscillator, shown in Figure 6a , is based on a delayed negative feedback loop mechanism, where cyclic gene expression is mediated by direct, or indirect, repression of the gene promoter by its protein product, after a delay that enables protein accumulation 27 . We 'virtualised' the transcriptional repression signal so that DDmCherry can inhibit its own expression. This is accomplished by implementing a 'virtual promoter' in silico by means of the microfluidics platform ( Figure 6b and Movie S11). At regular sampling times (60 min), mCherry fluorescence in the cell population is compared to a threshold level. If fluorescence is below the threshold, the promoter is activated by providing Dox+TMP to the cells, otherwise standard medium is provided. We chose the threshold to be 50% of the maximum fluorescence when cells are grown in the presence of Dox+TMP (Supporting Information). As microscopic images are taken at 60 min intervals, there is a minimum 60 min delay between the measurement of mCherry fluorescence and the delivery of the input to the cells. However, the effective delay ( in Figure 6a ) could be greater as this is affected also by DDmCherry transcription, translation and protein stability. We reasoned that the hybrid circuit should be able to generate oscillations because it would act as a delayed negative feedback loop. As shown in Figure 6c , periodic oscillations in fluorescence were indeed observed with a period of 490 min. In order to estimate the effective delay from the data, we used a simple mathematical model of a delayed negative feedback oscillator (Supporting Information). By fitting the model parameters to the data in Figure 6c , we obtained an estimate of the effective delay of 107 min, which, as expected, is greater than the 60 min sampling delay.
Discussion
In this work, we proved the generality and usefulness of the automated microfluidics feedback control platform for different applications and experimental testbeds. This technology can be easily implemented in any lab without specific training and at very limited costs, as it is based on the Diala-Wave system 28 , which does not require any dedicated pumps or valve and for which online tutorial guides are available (http://biodynamics.ucsd.edu/).
We have previously described a proof-of-concept approach to control gene expression in a microfluidics/microscopy set-up in a mammalian cell line 15 . Our initial work, however, was limited to set-point regulation of gene expression in single cell-line (CHO) using a rudimentary controller (Relay) which was unable to cope with oscillations around the set-point. Here, by means of a redesigned microfluidics-based platform, we precisely and robustly control both gene expression and endogenous signalling pathway activity in different mammalian cells of biotechnological and biomedical interest, including stem cells for the first time, with single-cell precision. We introduced a model-based control algorithm, which allowed us to cope with the slow response to inducer molecules preventing oscillations to occur, and an inducer molecule controller, which enable precise regulation of its concentration in time.
We demonstrated that it is possible to precisely regulate gene expression in CHO cells and mouse embryonic stems cells (mESCs) from inducible promoters. CHO cells are of extreme biotechnological interest and the workhorse in industry for recombinant protein production 29 .
Optimisation of the production process, however, requires the ability to accurately control the level and timing of gene expression in the host cell factory during the manufacturing process 30 . The automated microfluidics feedback control platform is an enabling technology in this setting and could be used for identifying optimal conditions for protein production in continuously perfused production processes, or to regulate the level of a protein product that is toxic if highly expressed.
Our results also pioneer the application of microfluidics-based control of gene expression in mESCs and pave the way for more sophisticated control of cellular behaviour in the context of regenerative medicine. Indeed, the dynamic expression of pluripotency genes is essential for cell fate determination [31] [32] [33] [34] [35] [36] , hence being able to control their dynamics at will provides researchers with unprecedented opportunities.
We also showed that it is possible to dynamically regulate in individual cells the activity of the mammalian target of rapamycin (mTOR), a key regulator of cell growth, metabolism and proliferation 37,38 whose dysregulation often underlies common diseases such as cancer 39 . Precise control of the mTOR signalling pathway activity will make it possible to quantitatively and dynamically study how mTOR regulates downstream biological processes such as autophagy, a key pathway of extreme interest for the therapy of neurodegenerative disorders.
Finally, we showed that our platform can be used to synthetise a hybrid genetic oscillator by interfacing biomolecular circuits with virtual in silico components. In the context of synthetic biology, bio-hybrid circuits may allow rapid prototyping of synthetic circuits, thus speeding up the development phase and hence broadening applicability.
Our approach is generasible to control other celluler features in addition to gene expression and protein localisation, such as cellular morphology. Indeed, any feature can be used as 'output' of the biological system to be controlled, as long as there is a molecule or treatment that can be used as 'input' to modify the chosen output. 
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